CAPTRUST Financial Advisors’s TransCode Therapeutics RNAZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-18	Closed	-$9.28K	–	2383
2024 Q3	$9.28K	Buy	18 +6	+50%	+$3.09K	﹤0.01%	2274
2024 Q2	$11.3K	Buy	+12	New	+$11.3K	﹤0.01%	2184
2024 Q1	–	Sell	-1	Closed	-$8.24K	–	2563
2023 Q4	$8.24K	Buy	+1	New	+$8.24K	﹤0.01%	2635